B3 · BRL

OFSA3

Ourofino S.A.

R$25.75+1.58% (R$0.40)
Day's range
R$25.50 – R$25.90
Day's volume
R$167.4k
52-week range
R$20.90 – R$34.69

Follow OFSA3 on Fuolio

See how OFSA3 weighs in your net worth, what it has paid you and how far it is from your target allocation.

Create a free account

OFSA3 in numbers

Market cap
R$1.4bn
P/E
5.88
P/B
1.68
Dividend yield (12m)
5.01%
Net debt/EBITDA
0.47

The 12-month dividend yield of OFSA3 is 5.01%, below its 5-year average of 5.28%.

OFSA3 price history

01/10/202530/09/2026
Compare with

OFSA3 risk and return

Monthly closes adjusted for splits and distributions.

Metric12 months36 months60 months
Return+24.54%+52.55%+21.65%
Volatility (annualised)25.27%32.40%30.74%
Largest drawdown-19.37%-28.35%-30.23%
Positive months6/1217/3628/60

How much did investing in OFSA3 return?

R$1,000.00 invested on 01/09/2021 would be worth R$1,046.60 today.

Value today in OFSA3
R$1,046.60
Return over the period
+4.66%
Return per year
+0.92%
In the Ibovespa
R$1,657.66

With dividends reinvested, before taxes and costs, at month-end closes. Past returns do not guarantee future ones.

OFSA3 fundamentals

Valuation

  • P/E
    5.88
  • P/B
    1.68
  • EV/EBITDA
    5.26
  • EV/EBIT
    6.08
  • EV/Revenue
    1.12
  • P/EBIT
    5.53
  • P/S
    1.02
  • P/OCF
    5.98
  • P/FCF
    24.56
  • Earnings yield
    16.45%
  • PEG ratio
    0.07
  • Earnings per share
    R$4.38
  • Book value per share
    R$15.33

Debt

  • Net debt
    R$137.1m
  • Net debt/EBITDA
    0.47
  • Net debt/Equity
    0.17
  • Debt/Equity
    0.61
  • Current ratio
    3.61
  • Quick ratio
    2.39
  • Cash ratio
    1.20

Efficiency

  • Gross margin
    52.02%
  • EBITDA margin
    21.27%
  • Operating margin
    18.39%
  • Net margin
    17.29%
  • Asset turnover
    0.85

Profitability

  • ROE
    28.55%
  • ROA
    14.62%
  • ROIC
    25.93%
  • Payout
    29.48%

Growth

  • Revenue CAGR (5 years)
    10.06%
  • Earnings CAGR (5 years)
    14.76%
  • Revenue growth (year)
    19.54%
  • Earnings growth (year)
    65.50%
  • Revenue growth (quarter)
    26.66%
  • Earnings growth (quarter)
    80.39%

What is OFSA3's fair price?

Two classic value formulas, with today's numbers. The current price is R$25.75.

Graham's fair price
R$38.85
50.87% above the price

√(22.50 × R$4.38 × R$15.33)

Benjamin Graham paid no more than a P/E of 15 and a P/B of 1.5. Their product, 22.5, times earnings (EPS) and book value per share gives the fair price.

Bazin's ceiling price
R$20.62
19.94% below the price

R$1.24 (5-year average) ÷ 6%

Décio Bazin only bought shares yielding at least 6% a year in distributions. The ceiling price is the average dividend per share of recent years divided by 6%.

Graham ignores growth and debt; Bazin assumes past distributions will repeat. They are reference points for comparison, not a buy recommendation.

OFSA3 indicators by year

Multiples at each year's closing price; margins and returns from that year's accounts.

Indicator20252024202320222021202020192018
P/E5.587.77-28.0810.0511.9122.8550.1326.41
P/B1.561.382.041.782.123.664.713.99
EV/EBITDA5.385.2113.067.459.3517.1326.5116.52
Dividend yield15.37%1.74%1.82%4.58%2.88%0.59%1.04%0.96%
Earnings per shareR$4.12R$2.49-R$0.93R$2.42R$2.11R$1.66R$0.86R$1.28
Book value per shareR$14.77R$14.02R$12.78R$13.64R$11.89R$10.40R$9.13R$8.45
ROE27.90%17.76%-7.25%17.75%17.77%16.00%9.40%15.10%
ROIC22.83%16.07%0.00%16.02%14.83%13.72%7.87%12.01%
Gross margin51.68%50.52%45.77%50.72%49.41%51.22%49.65%55.01%
EBITDA margin22.43%21.91%12.42%20.10%18.65%17.60%15.56%20.96%
Net margin18.15%13.11%-5.30%12.55%12.59%12.29%7.47%11.68%
Net debt/EBITDA0.870.561.091.181.311.172.451.80

OFSA3 financial statements

Line202520242023202220212020
Net revenueR$1.2bnR$1bnR$943.3mR$1bnR$905mR$730.1m
Cost of sales-R$592m-R$507.1m-R$511.5m-R$513m-R$457.8m-R$356.1m
Gross profitR$633mR$517.7mR$431.7mR$528.1mR$447.2mR$374m
EBITDAR$274.8mR$224.5mR$117.2mR$209.3mR$168.8mR$128.5m
EBITR$236.5mR$186.8mR$81mR$177.3mR$141.1mR$102.1m
Net finance result-R$17.2m-R$9.7m-R$26.8m-R$30.3m-R$15.4m-R$8.3m
Profit before taxR$219.3mR$177.1mR$54.3mR$147.1mR$125.7mR$93.8m
Income taxR$3m-R$42.8m-R$104.2m-R$16.4m-R$11.7m-R$4.1m
Net incomeR$222.3mR$134.3m-R$50mR$130.7mR$114mR$89.7m

Figures the company filed with the CVM. Debt excludes leases; each quarter is that quarter alone.

OFSA3 against its sector

The same indicators for the company's other shares and the sector's largest stocks.

StockP/EP/BDividend yield (12m)ROEMarket cap
OFSA3Ourofino5.881.685.01%28.55%R$1.4bn
HYPE3HYPERA S.A.9.721.184.48%12.10%R$17bn
BLAU3BLAU FARMACÊUTICA S.A.10.411.048.65%10.02%R$2.4bn
BIOM3BIOMM S.A.26.852.500.00%9.33%R$814.3m
BALM3BAUMER S.A.9.761.2821.91%13.16%R$178.7m
BALM4BAUMER S.A.6.420.8433.31%13.16%R$178.7m

Does OFSA3 pay dividends?

Dividend yield per year

  • 0.00%2017
  • 0.96%2018
  • 1.04%2019
  • 0.59%2020
  • 2.88%2021
  • 4.58%2022
  • 1.82%2023
  • 1.74%2024
  • 15.37%2025
  • 5.01%2026
Payment history
TypeLast day to ownPaymentPer share
Dividend16/04/202630/04/2026R$0.17
Dividend16/04/202630/04/2026R$0.19
Interest on equity23/12/202530/04/2026R$0.93
Interest on equity17/04/202505/05/2025R$0.58
Dividend17/04/202505/05/2025R$0.06
Dividend17/04/202505/05/2025R$0.09
Interest on equity20/12/202405/05/2025R$0.58
Other30/12/202431/01/2025R$2.23
Dividend29/04/202413/05/2024R$0.34
Interest on equity19/12/202328/12/2023R$0.28
Dividend14/04/202311/05/2023R$0.20
Interest on equity16/12/202229/12/2022R$0.44
See all 31 distributions
Earlier distributions
TypeLast day to ownPaymentPer share
Dividend16/12/202229/12/2022R$0.44
Dividend20/04/202231/05/2022R$0.24
Interest on equity17/12/202129/12/2021R$0.30
Dividend09/04/202130/04/2021R$0.17
Interest on equity23/12/202030/04/2021R$0.25
Dividend14/10/202027/10/2020R$0.19
Interest on equity19/12/201923/06/2020R$0.02
Interest on equity19/12/201831/05/2020R$0.02
Interest on equity14/12/201831/05/2019R$0.13
Dividend29/03/201920/05/2019R$0.18
Interest on equity14/12/201820/05/2019R$0.14
Interest on equity19/12/201731/05/2018R$0.11
Dividend13/04/201825/04/2018R$0.03
Dividend13/04/201825/04/2018R$0.07
Interest on equity14/12/201725/04/2018R$0.11
Interest on equity21/12/201509/05/2016R$0.09
Dividend28/04/201508/05/2015R$0.18
Dividend29/04/2016—R$0.30
Interest on equity02/01/2015—R$0.07

About Ourofino

Sector
Consumo Não Cíclico
Segment
Medicamentos e Outros Produtos
Listing segment
Novo Mercado
Tag along
100.00%
Free float
42.94%
Shares issued
53.95m ordinary
Average daily trading
R$302.3k
Listed since
21/10/2014
CNPJ
20.258.278/0001-70

Ourofino S.A. é uma empresa brasileira especializada em medicamentos e produtos farmacêuticos para saúde animal e humana. A companhia atua no segmento de farmacêutica, oferecendo uma ampla gama de medicamentos, suplementos e produtos de saúde. Ourofino opera com foco em inovação, pesquisa e desenvolvimento de novos produtos, atendendo mercados domésticos e internacionais. A empresa está posicionada como um player importante no segmento farmacêutico brasileiro, contribuindo para a saúde e bem-estar de pessoas e animais.

Investor website
ShareholdersAs of 31/12/2026, from the Formulário de Referência filed with the CVM.
ShareholderOrdinaryPreferredTotal
Mitsui & Co., Ltd29.44%0.00%29.44%
JARDEL MASSARIControlling28.76%0.00%28.76%
NORIVAL BONAMICHIControlling27.97%0.00%27.97%
Outros13.50%0.00%13.50%
Ações Tesouraria0.34%0.00%0.34%

Questions about OFSA3

How much is OFSA3 today?

OFSA3 is at R$25.75 (1.58% on the day), last traded on 30/09/2026.

How much did OFSA3 pay in dividends in 2025?

OFSA3 paid R$3.54 per share in 2025, a dividend yield of 15.37%.

What are the P/E and P/B of OFSA3?

OFSA3 trades at a P/E of 5.88 and a P/B of 1.68.

How much did OFSA3 return in 12 months?

OFSA3 returned 24.54% in 12 months, with annualised volatility of 25.27% and a largest drawdown of -19.37%.

What sector is OFSA3 in?

Ourofino is in the Consumo Não Cíclico sector, Medicamentos e Outros Produtos segment.